Loading...
Fetching results...
0 items found

P056: The Importance of evaluating for potential underlying causes of kidney stones: A survey of physician experiences in diagnosing Primary Hyperoxaluria type 1 (PH1)

Authors
Danese D. 1 , Murray R. 2 , Monpara A. 1 , Ben-David R. 3 , Crockett T. 3 , Holloway M. 3 , Barr K. 3 , Doyle S. 3 , Howie K. 3
Institutions
1Alnylam Pharmaceuticals, Medical Affairs, Cambridge, United States of America, 2Alnylam Pharmaceuticals, Market Insights, Cambridge, United States of America, 3Magnolia Innovation, Research Department, Hoboken, United States of America, 4
Event
5th Meeting of the EAU Section of Urolithiasis (EULIS19)
Date – Time - Location
03 October 2019, 14:00 - 16:00, Room Foscolo
Session
Poster session 4 - Paediatrics
Topic
Medical management and Basic research in urolithiasis - Genetics in stone disease
  • © 2022 European Association of Urology
  • Disclaimer